This is the authors' abstract. We don't add key points for this paper.
A 32 year old woman with Dejerine-Sottas disease and negative family history is reported. Clinical onset of her condition was with congenital weakness of her distal four extremities, accompanied by peripheral facial nerve weakness, deafness, and nystagmus. She has used a wheelchair all her life. Sural nerve biopsy showed proliferation of Schwann cells, extensive endoneural fibrosis, axon loss, and demyelination. MNCVs showed marked slowing. MRI of the brain was normal. Molecular genetic studies indicated a de novo dominant missense point mutation of exon 3 of the peripheral myelin protein 22 gene at nucleotide 264 causing replacement of serine with leucine.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ionâşescu et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: